Rheumatology Network Newsletter

To view this email as a web page, click here.

Upadacitinib Demonstrates Positive Outcomes as Monotherapy in Rheumatoid Arthritis

Rheumatoid arthritis patients who failed first-line methotrexate achieved better outcomes with upadacitinib monotherapy, shows a new clinical trials report.

Baricitinib Versatile and Effective in Rheumatoid Arthritis

Rheumatoid arthritis patients treated with baricitinib at any point during their treatment, experience improved outcomes, a new clinical trials report shows.

• A Clinical Update on Baricitinib for Rheumatoid Arthritis

• Baricitinib and Cardiovascular Events

• Risk of Infection in Psoriasis Lower with Some Biologics

• Which biologics do patients like best?

• 8 treatment recommendations for PsA

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.